logging in or signing up Presentation Jean Pierre Allain Talya Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINTLite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 368 Category: Entertainment License: All Rights Reserved Like it (0) Dislike it (0) Added: October 24, 2007 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript GBV-C, WNV & Dengue V in Ghanaian donors, women & children : GBV-C, WNV & Dengue V in Ghanaian donors, women & children C Li, D Candotti, JP Allain National Blood Service & University of CambridgeTesting algorithm: Testing algorithm Screening with Triplex NAT; probes labeled with: CY5 GBV-C, FAM WNV, HEX Dengue Confirmation with virus specific nested RT-PCR Confirmed positive quantified by single virus QPCR for VL Genotyping by sequencing E2 region and phylogenetic analysis Antibody testing with Panbio kits Quantification of GBV-C RNA load: Quantification of GBV-C RNA load RNA from 200 l of plasma Reference high + plasma: last + dilution defines arbitrary unit GBV-C reference curve 40Ct = 1 AU/mlDistribution of GBV-C markers in blood donors and pregnant women (Li et al. AIDS 2006, 20:379-386): Distribution of GBV-C markers in blood donors and pregnant women (Li et al. AIDS 2006, 20:379-386) Blood donations Pregnant women HIV-1 status Neg Pos Neg Pos N samples 140 96 140 86 % RNA+ 12.91 21.9 25 27.9 % anti-E2 + 3.8 14.5 18 17.3 % total markers 16.5 36.4 39.8 38.62 1. P<0.01 ; 2. Total is lower than RNA+Ab as some samples carry both Slide5: Distribution of HIV-1 RNA load according to GBV-C RNA status GBV-C- GBV-C+ (P< 0.01)Slide6: Screening for GBV-C RNA in HIV-1 RNA positive and negative mothers and paired cord blood samplesSlide7: Prevalence of GBV-C markers with agePhylogenetic tree of GBV-C E2 region in Ghana: Phylogenetic tree of GBV-C E2 region in GhanaSlide9: Age distribution of IgG antibody to West Nile VirusConclusions : Conclusions • GBV-C prevalence is high (16-40%) and genotype 1 is dominant • GBV-C viraemia is twice as frequent as neutralising antibodies • HIV-1 RNA load is lower in GBV-C viraemic patients • GBV-C vertical transmission is rare and horizontal transmission appears predominant in West Africa (related to genotype?) • Most WNV infections occur early in life, absence of viraemia, short window period --> minimal risk of transmission by transfusion • Dengue virus does not seem prevalent in Ghana Slide11: Acknowledgements KATH Blood Bank, Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana: Francis Sarkodie, Shirley Owusu-Ofori National Institute for Biological Standards and Control, UK: Sally Baylis Dept of Health & Human Services, F D A, USA: Indira Hewlett INTS Paris, France: Jean-Jacques Lefrere, M Mariotti Roche, USA: Jim Gallarda University of Malaysia, Sarawak: Jane Cardosa You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.
Presentation Jean Pierre Allain Talya Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINTLite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 368 Category: Entertainment License: All Rights Reserved Like it (0) Dislike it (0) Added: October 24, 2007 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript GBV-C, WNV & Dengue V in Ghanaian donors, women & children : GBV-C, WNV & Dengue V in Ghanaian donors, women & children C Li, D Candotti, JP Allain National Blood Service & University of CambridgeTesting algorithm: Testing algorithm Screening with Triplex NAT; probes labeled with: CY5 GBV-C, FAM WNV, HEX Dengue Confirmation with virus specific nested RT-PCR Confirmed positive quantified by single virus QPCR for VL Genotyping by sequencing E2 region and phylogenetic analysis Antibody testing with Panbio kits Quantification of GBV-C RNA load: Quantification of GBV-C RNA load RNA from 200 l of plasma Reference high + plasma: last + dilution defines arbitrary unit GBV-C reference curve 40Ct = 1 AU/mlDistribution of GBV-C markers in blood donors and pregnant women (Li et al. AIDS 2006, 20:379-386): Distribution of GBV-C markers in blood donors and pregnant women (Li et al. AIDS 2006, 20:379-386) Blood donations Pregnant women HIV-1 status Neg Pos Neg Pos N samples 140 96 140 86 % RNA+ 12.91 21.9 25 27.9 % anti-E2 + 3.8 14.5 18 17.3 % total markers 16.5 36.4 39.8 38.62 1. P<0.01 ; 2. Total is lower than RNA+Ab as some samples carry both Slide5: Distribution of HIV-1 RNA load according to GBV-C RNA status GBV-C- GBV-C+ (P< 0.01)Slide6: Screening for GBV-C RNA in HIV-1 RNA positive and negative mothers and paired cord blood samplesSlide7: Prevalence of GBV-C markers with agePhylogenetic tree of GBV-C E2 region in Ghana: Phylogenetic tree of GBV-C E2 region in GhanaSlide9: Age distribution of IgG antibody to West Nile VirusConclusions : Conclusions • GBV-C prevalence is high (16-40%) and genotype 1 is dominant • GBV-C viraemia is twice as frequent as neutralising antibodies • HIV-1 RNA load is lower in GBV-C viraemic patients • GBV-C vertical transmission is rare and horizontal transmission appears predominant in West Africa (related to genotype?) • Most WNV infections occur early in life, absence of viraemia, short window period --> minimal risk of transmission by transfusion • Dengue virus does not seem prevalent in Ghana Slide11: Acknowledgements KATH Blood Bank, Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana: Francis Sarkodie, Shirley Owusu-Ofori National Institute for Biological Standards and Control, UK: Sally Baylis Dept of Health & Human Services, F D A, USA: Indira Hewlett INTS Paris, France: Jean-Jacques Lefrere, M Mariotti Roche, USA: Jim Gallarda University of Malaysia, Sarawak: Jane Cardosa